Gemini Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GMTX and buy or sell other stocks, ETFs, and their options commission-free!About GMTX
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
CEOJohn D. Quisel, PhD
CEOJohn D. Quisel, PhD
Employees84
Employees84
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2017
Founded2017
Employees84
Employees84
GMTX Key Statistics
Market cap2.33B
Market cap2.33B
Price-Earnings ratio-17.17
Price-Earnings ratio-17.17
Dividend yield—
Dividend yield—
Average volume470.68K
Average volume470.68K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$99.50
52 Week high$99.50
52 Week low$30.82
52 Week low$30.82
Stock Snapshot
Gemini Therapeutics(GMTX) stock is priced at $66.65, giving the company a market capitalization of 2.33B. It carries a P/E multiple of -17.17.
During the trading day, Gemini Therapeutics(GMTX) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 470.68K.
The stock's 52-week range extends from a low of $30.82 to a high of $99.50.
The stock's 52-week range extends from a low of $30.82 to a high of $99.50.
People also own
Based on the portfolios of people who own GMTX. This list is generated using Robinhood data, and it’s not a recommendation.